Global Diagnostics PCR Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Diagnostics PCR market size was valued at US$ 566 million in 2024 and is forecast to a readjusted size of USD 655 million by 2031 with a CAGR of 2.1% during review period.
PCR is the Gold Standard in Diagnostic Testing. Polymerase chain reaction (PCR) is able to copy and multiply specific target DNA molecules has opened the door to diagnosing diseases across multiple areas quickly, accurately, and as time progresses at lower cost. Polymerase chain reaction (PCR) is a quick, easy way to create unlimited copies of DNA from just one original strand. These millions of copies of a section of DNA are made in just a few hours with the goal to recreate enough DNA for multiple testing uses, such as sequencing or infection identification.
Global Diagnostics PCR key players include Thermo Fisher Scientific, Bio-rad, Roche, Qiagen, Bioer, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 40%, followed by Europe and China, total have a share over 40 percent. In terms of product, Real-Time PCR is the largest segment, with a share about 55%. And in terms of application, the largest application is Hospital, followed by Independent Laboratories.
This report is a detailed and comprehensive analysis for global Diagnostics PCR market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Diagnostics PCR market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Diagnostics PCR market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Diagnostics PCR market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Diagnostics PCR market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diagnostics PCR
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diagnostics PCR market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Roche, Bio-rad, Qiagen, Agilent, Bioer, Analytik Jena, Techne, Biosynex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Diagnostics PCR market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Real-Time PCR
Digital PCR
Other
Market segment by Application
Hospital
Independent Laboratories
Other
Major players covered
Thermo Fisher Scientific
Roche
Bio-rad
Qiagen
Agilent
Bioer
Analytik Jena
Techne
Biosynex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diagnostics PCR product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Diagnostics PCR, with price, sales quantity, revenue, and global market share of Diagnostics PCR from 2020 to 2025.
Chapter 3, the Diagnostics PCR competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostics PCR breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Diagnostics PCR market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Diagnostics PCR.
Chapter 14 and 15, to describe Diagnostics PCR sales channel, distributors, customers, research findings and conclusion.